120 related articles for article (PubMed ID: 347464)
21. Assessment of drug therapy in chronic brain failure.
Lloyd-Evans S; Brocklehurst JC; Palmer MK
Gerontology; 1978; 24(4):304-11. PubMed ID: 342341
[TBL] [Abstract][Full Text] [Related]
22. Controlled study of dihydroergotoxine in gerontopsychiatric patients.
Slánská J
Act Nerv Super (Praha); 1989 Apr; 31(1):53-5. PubMed ID: 2782002
[No Abstract] [Full Text] [Related]
23. [Experiences with Card-hydergine in patients with cardiac insufficiency and cerebrovascular disorders in professional practice].
Kohler H
Med Monatsschr; 1976 Nov; 30(11):516-8. PubMed ID: 792670
[No Abstract] [Full Text] [Related]
24. Effect of ergot alkaloids on serum prolactin in non-psychotic organic brain syndrome of the elderly.
Gross RJ; Eisdorfer CE; Schiller HS; Cox G
Exp Aging Res; 1979 Aug; 5(4):293-302. PubMed ID: 520386
[TBL] [Abstract][Full Text] [Related]
25. Event related evoked potentials in dementia.
Breeze RW
Br J Clin Pract Suppl; 1985 Jun; 39():43-4. PubMed ID: 3929815
[No Abstract] [Full Text] [Related]
26. [Controlled clinical study of use of dihydroergocristine in cerebral and periferal vascular disorders].
Calisti G; Biscarini L; Miseo A
Clin Ter; 1977 Nov; 83(4):371-86. PubMed ID: 414875
[No Abstract] [Full Text] [Related]
27. Hydergine-thioridazine combination in the treatment of psychopathological states in old age.
Predescu V; Giurezu T; Tudorache D; Nica S; Ionescu R; Nicolschi L; Nitrurad A; Popvici E; Curelaru S
Act Nerv Super (Praha); 1974 Aug; 16(3):237-8. PubMed ID: 4214302
[No Abstract] [Full Text] [Related]
28. Dementia: differential diagnosis and treatment.
Yesavage J
Geriatrics; 1979 Sep; 34(9):51-9. PubMed ID: 38188
[TBL] [Abstract][Full Text] [Related]
29. [Controlled double-blind study of the clinical equivalent of two posologic regimens of Hydergine: 1 x 4,5mg compared to 3 x 1,5mg per day].
Piguet PV; Zoufal Z
Rev Med Suisse Romande; 1981 Feb; 101(2):157-63. PubMed ID: 7015453
[No Abstract] [Full Text] [Related]
30. Hydergine for schizophrenia.
Cohen MR; Pary R; Burns R
J Clin Psychiatry; 1987 Jan; 48(1):39-40. PubMed ID: 3542983
[No Abstract] [Full Text] [Related]
31. Hydergine and cyclosporin nephrotoxicity.
Nussenblatt RB; Austin HA; Palestine AG; Preuss HG
Lancet; 1986 May; 1(8491):1220-1. PubMed ID: 2871464
[No Abstract] [Full Text] [Related]
32. Design aspects of clinical trials with ergot alkaloids: a comparison of two geriatric behavioral rating scales.
Yesavage JA; Adey M
Adv Biochem Psychopharmacol; 1980; 23():357-62. PubMed ID: 7395622
[No Abstract] [Full Text] [Related]
33. The effects of Hydergine on neurotransmitters.
Ermini M
Br J Clin Pract Suppl; 1985 Jun; 39():11-5. PubMed ID: 2864053
[No Abstract] [Full Text] [Related]
34. The efficacy of the cerebral metabolic enhancers in the treatment of senile dementia.
Branconnier RJ
Psychopharmacol Bull; 1983; 19(2):212-9. PubMed ID: 6408682
[No Abstract] [Full Text] [Related]
35. Hydergine helpful for Alzheimer's disease.
Geriatrics; 1979 Oct; 34(10):23. PubMed ID: 478308
[No Abstract] [Full Text] [Related]
36. Ergoloid mesylates for senile dementias: unanswered questions.
Hollister LE; Yesavage J
Ann Intern Med; 1984 Jun; 100(6):894-8. PubMed ID: 6372566
[TBL] [Abstract][Full Text] [Related]
37. Pharmacological approaches in the treatment of senile dementia.
Markstein R
Eur Neurol; 1989; 29 Suppl 3():33-41. PubMed ID: 2575520
[TBL] [Abstract][Full Text] [Related]
38. Dihydroergocryptine in the management of senile psycho-organic syndrome.
Scarzella L; Bono G; Bergamasco B
Int J Clin Pharmacol Res; 1992; 12(1):37-46. PubMed ID: 1526697
[TBL] [Abstract][Full Text] [Related]
39. [Evaluation of the effectiveness of dihydroergotoxine (DHET) in the treatment of chronic cerebral ischemia syndromes in elderly patients].
Derejczyk J; Panuś K
Wiad Lek; 1986 Jun; 39(12):818-24. PubMed ID: 3535261
[No Abstract] [Full Text] [Related]
40. [Clinical trials with dihydroergocristine in patients with vascular and cerebral insufficiency].
Ingelmo M; Vivancos J; Peri J; Balcells Gorina A
Rev Clin Esp; 1980 Dec; 159(6):399-402. PubMed ID: 6784197
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
